Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a feasibility study to perform image-guided liver biopsies in 25 patients who have pancreatic cancer with liver metastasis (cancer in the pancreas that has spread to the liver). This will contribute with samples for the bio-bank (bank of tumors) and develop xenografts (human tumors growing in mice) for further analysis of genes.
This study might bring a better understanding of the metastatic pancreatic cancer and evaluate the differences between the metastatic and the primary pancreatic cancer (the type that does not have metastasis).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pancreatic cancer with liver metastases | Tumor tissue biopsy, blood samples |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Number of patients with adverse events due to biopsies | Monitoring adverse events during trial related to biopsies | up to 2 years |
| Number of successful xenografts | determine the "take rate" or success of establishing xenografts | up to 2 years |
| Number of similarities and differences between original patient tumor sample with xenograft sample | complete histological and molecular comparison of original patient sample with murine xenograft | up to 2 years |
| Engraftment rate compared to clinical data (response to treatment, disease-free survival, overall survival) | determine the correlation between engraftment rate and clinical data (response to treatment, disease-free survival, overall survival). | up to date of death from any cause |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Pancreatic cancer patients with liver metastases
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Neesha Dhani, M.D. | Princess Margaret Cancer Centre | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Princess Margaret Cancer Centre | Toronto | Ontario | M5G 2M9 | Canada |
Not provided
| ID | Term |
|---|---|
| D010190 | Pancreatic Neoplasms |
| ID | Term |
|---|---|
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004701 | Endocrine Gland Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Tumor tissue
| D004066 |
| Digestive System Diseases |
| D010182 | Pancreatic Diseases |
| D004700 | Endocrine System Diseases |